EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC 4.0

Evaluation of Empirical Antifungal Treatments in Patients with Neutropenic Fever in Imam Hossein Hospital, Tehran, 2017 - 2018

Fahimeh Hadavand, Simin Dokht Shoaei, Hamid Noroozi

Journal of Archives in Military Medicine · 2022

DOI: 10.5812/jamm-122775 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Archives in Military Medicine, 2022. Verfasst von Fahimeh Hadavand und 2 weiteren Autor:innen. Die Arbeit nennt 27 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0).

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Invasive fungal infections are among the most important causes of death in patients with neutropenic fever. Early detection of the cause of neutropenia and appropriate treatment, including experimental antifungal therapy, plays a key role in reducing mortality and cutting financial costs for the individual and society.

Methods

In this retrospective study, the records of 33 patients with fever and neutropenia who received antifungal drugs (including Amphotericin B, Voriconazole, Caspofungin, and Fluconazole) were evaluated. Neutropenia was defined as episodes of fever (axillary temperature > 38.2°C or oral temperature > 37.7°C) and neutrophil count < 500 /μL persistent for five days despite antibacterial therapy without an infectious etiology. For statistical analysis, SPSS software version 21 was used.

Results

In this study, out of 33 neutropenic patients receiving antifungal therapy, a fungal agent was defined in 19 patients (59%). Mucor species was the most common cause of fungal infections, followed by aspergillus and candida. Liposomal Amphotericin B and Caspofungin were the most common antifungal agents used for treating patients with neutropenic fever. Antifungal therapy in neutropenic patients resulted in 50% recovery and 50% mortality. Statistical analysis showed that neutropenic patients did not have a significant difference in response to treatments based on age groups and gender.

Conclusions

The study highlights the importance of experimental therapy in neutropenic patients based on clinical criteria and risk factors, and with a diagnostic approach, rather than general treatment.

Zitieren

APA

Hadavand, F., Shoaei, S. D., & Noroozi, H. (2022). Evaluation of Empirical Antifungal Treatments in Patients with Neutropenic Fever in Imam Hossein Hospital, Tehran, 2017 - 2018. Journal of Archives in Military Medicine. https://doi.org/10.5812/jamm-122775

Vancouver

Hadavand F, Shoaei SD, Noroozi H. Evaluation of Empirical Antifungal Treatments in Patients with Neutropenic Fever in Imam Hossein Hospital, Tehran, 2017 - 2018. Journal of Archives in Military Medicine. 2022. doi:10.5812/jamm-122775

BibTeX
@article{Hadavand2022,
  author = {Hadavand, Fahimeh and Shoaei, Simin Dokht and Noroozi, Hamid},
  title = {Evaluation of Empirical Antifungal Treatments in Patients with Neutropenic Fever in Imam Hossein Hospital, Tehran, 2017 - 2018},
  journal = {Journal of Archives in Military Medicine},
  year = {2022},
  doi = {10.5812/jamm-122775}
}
Kostenlos starten →